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MBoC | PERSPECTIVE

CARMIL family proteins as multidomain
regulators of actin-based motility
Benjamin C. Stark, M. Hunter Lanier, and John A. Cooper*
Department of Biochemistry and Molecular Biophysics and Department of Cell Biology and Physiology,
Washington University School of Medicine, St. Louis, MO 63110

ABSTRACT CARMILs are large multidomain proteins that regulate the actin-binding activity
of capping protein (CP), a major capper of actin filament barbed ends in cells. CARMILs bind
directly to CP and induce a conformational change that allosterically decreases but does not
abolish its actin-capping activity. The CP-binding domain of CARMIL consists of the CP-interaction (CPI) and CARMIL-specific interaction (CSI) motifs, which are arranged in tandem.
Many cellular functions of CARMILs require the interaction with CP; however, a more surprising result is that the cellular function of CP in cells appears to require binding to a CARMIL or
another protein with a CPI motif, suggesting that CPI-motif proteins target CP and modulate
its actin-capping activity. Vertebrates have three highly conserved genes and expressed isoforms of CARMIL with distinct and overlapping localizations and functions in cells. Various
domains of these CARMIL isoforms interact with plasma membranes, vimentin intermediate
filaments, SH3-containing class I myosins, the dual-GEF Trio, and other adaptors and signaling
molecules. These biochemical properties suggest that CARMILs play a variety of membraneassociated functions related to actin assembly and signaling. CARMIL mutations and variants
have been implicated in several human diseases. We focus on roles for CARMILs in signaling
in addition to their function as regulators of CP and actin.
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INTRODUCTION
The dynamics of actin filament assembly and disassembly play important roles in many biological processes, both normal and pathological (Pollard and Cooper, 2009). Actin filaments grow and shrink
by addition and loss, respectively, of actin subunits at the ends of
filaments. The barbed (plus) end of the filament is favored over the
pointed (minus) end for assembly, both thermodynamically and
kinetically (Pollard, 2016), and cells control their shape and migration by regulating barbed-end filament assembly spatially and temporally (Shekhar et al., 2016). Examples of such regulation are
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numerous and affect a wide range of processes, including development and differentiation (Harris et al., 2009), immunity and inflammation (Marcos-Ramiro et al., 2014), and cancer cell invasion and
metastasis (Kumar and Weaver, 2009; Mierke, 2013).
The growth of actin filament barbed ends by the addition of subunits is a major mechanism by which actin filaments form and assemble to do work in cells. A free actin subunit is able to add to a
free barbed end on its own, and a number of factors that promote
this process have been discovered and play important roles (Pollard,
2016). In cells, the creation of free barbed ends correlates with and
appears to be sufficient to induce actin filament polymerization
(Bailly et al., 1999; Huang et al., 1999; Ghosh et al., 2004). Free
barbed ends can be generated in several ways: de novo assembly
of a new actin filament from free actin subunits, severing of an existing actin filament, and uncapping of the barbed end of a capped
filament. Free barbed ends will stop growing if they are functionally
capped, and capping is a feature of both termination and promotion of actin assembly, depending on the context of polymerases
and other regulators (Pollard, 2016).
One major mediator for capping the barbed end of filaments is
capping protein (CP), an obligate α/β heterodimer found in essentially all eukaryotic cells. A small number of direct-binding inhibitors
of CP have been discovered (reviewed in Cooper and Sept, 2008;
1713

Edwards et al., 2014), and in vitro, purified CP can be inhibited by
phosphatidylinositol (4,5)-bisphosphate and other anionic phospholipids (Heiss and Cooper, 1991; Kuhn and Pollard, 2007; Li et al.,
2012), by the protein V-1 (Bhattacharya et al., 2006; Fujiwara et al.,

2014), and by a diverse set of proteins that contain a conserved
capping protein interaction (CPI) motif (Hernandez-Valladares et al.,
2010; Edwards et al., 2014). CPI-motif proteins can remove CP from
the barbed end (Edwards et al., 2014) and appear to be required for
normal CP function (Edwards et al., 2015). This review focuses on
the CPI-containing CP, Arp2/3, myosin-I
linker (CARMIL) family of proteins and their
roles as regulators of CP activity and scaffolding molecules for signaling pathways.

CARMIL-FAMILY PROTEINS
CARMIL-family proteins are large, highly
conserved, multidomain homodimers. CARMILs were discovered in Acanthamoeba
(Acan125) and Dictyostelium (p116) based
on direct binding of their proline-rich domain (PRD) to the Src homology 3 (SH3) domain of a subset of class I myosins (Xu et al.,
1995, 1997; Zot et al., 2000; Jung et al.,
2001). A myosin I SH3 domain was used as
an affinity ligand in the purification of
amoeba CARMILs from cells in a tight complex with CP and Arp2/3 complex (Jung
et al., 2001). Amoeba CARMILs possess
verprolin-like and acidic regions that are
capable of activating Arp2/3 complex for
nucleation of actin polymerization (Jung et al.,
2001); however, these two regions do not
appear to be present in vertebrate CARMILs, and CARMIL1 does not appear to bind
or activate Arp2/3 complex (Yang et al.,
2005; Liang et al., 2009).
Amoebozoa and invertebrates have one
gene encoding CARMIL, whereas vertebrates have three (Liang et al., 2009; Edwards et al., 2014; Stark and Cooper, 2015),
and the genomes of fungi and plants appear
to lack CARMIL homologues altogether. The
three vertebrate isoforms, CARMIL1, 2, and
3, can be defined and distinguished from
each other by conserved differences in their
amino acid sequences (Figure 1).

CARMIL-protein domain architecture

FIGURE 1: Conservation and domain architecture of CARMIL proteins. (A) Domain architecture
of CARMIL proteins, illustrating the arrangement of the PH domain, linker (L), N-cap (N), LRR
domain, C-cap (C), HD, CBR consisting of a CPI motif and a CSI motif, MBD, and a PRD.
Sequence alignment of the CBR for selected CARMILs, including the three vertebrate isoforms
in zebrafish, mouse, and human (encoded by three separate genes). The alignment includes
sequences for invertebrates, which lack the CSI motif region or lack residues known to be
required for the CSI-CP interaction (Zwolak et al., 2010b). Shaded residues are identical to the
consensus sequences. (B) Unrooted phylogenetic tree showing the relationships among CARMIL
proteins, revealing five groups of CARMIL genes. Vertebrate genomes have three genes that
encode three conserved isoforms—CARMIL1, CARMIL2, and CARMIL3—and invertebrates have
a single CARMIL gene and isoform. Invertebrate CARMILs can be further classified into those
that contain a CSI motif and those that do not.
1714 | B. C. Stark et al.

Vertebrate CARMILs share a common domain architecture (Zwolak et al., 2013), illustrated in Figure 1. The N-terminus has a
noncanonical pleckstrin-homology (PH) domain, followed by a leucine-rich repeat (LRR)
domain. The PH and LRR domains are connected by an apparently rigid linker; this
linker and the N-cap region of the LRR
domain contain conserved amino acid
sequences that are highly distinctive for
CARMILs, but they serve a function as yet
unknown. These sequences have been used
to aid in the identification of CARMILs from
various organisms (Liang et al., 2009; Zwolak
et al., 2013; Stark and Cooper, 2015). The
LRR domain is followed by a helical dimerization (HD) domain, and the C-terminal half
of the protein consists of an extended
Molecular Biology of the Cell

intrinsically disordered region. The disordered region contains a CPbinding region (CBR) made up of a CPI motif and a CARMIL-specific
interaction (CSI) motif arranged in tandem, followed by a short basic
and hydrophobic membrane-binding domain (MBD) and a prolinerich domain (PRD) that binds SH3 domains of class I myosins and
other proteins (Liang et al., 2009; Edwards et al., 2013; Zwolak et al.,
2013; Roncagalli et al., 2016). We discuss these domains in detail,
with consideration for the differences between isoforms.

Pleckstrin-homology domain
The noncanonical PH domain was identified by biochemical and
structural studies of mouse CARMIL1, including x-ray crystallography (Zwolak et al., 2013). The PH domain binds monophosphorylated phosphatidylinositides—phosphatidylinositol 3-phosphate, phosphatidylinositol 4-phosphate, and phosphatidylinositol
5-phosphate—with high specificity. In contrast to canonical PH
domains, the residues important for phospholipid binding are
not in the traditionally recognized lipid-binding pocket (Ferguson
et al., 2000; Lemmon, 2007); instead, the key residues lie near
the interface of the PH domain and the LRR domain (Zwolak
et al., 2013). Removal of the PH domain from the CARMIL1 Nterminus decreases the degree of plasma membrane localization
in cells, confirming the physiological importance of phospholipid
binding (Zwolak et al., 2013).
In contrast, the PH domain of CARMIL2 lacks the conserved residues needed for phospholipid binding, based on sequence alignments (Zwolak et al., 2013). As predicted, the CARMIL2 PH domain
is not sufficient to target green fluorescent protein (GFP) to the
plasma membrane (Lanier et al., 2015). For CARMIL3, the PH
domain has not been studied experimentally, but its sequence is
similar to that of CARMIL1, including the conservation of the phospholipid-binding residues.

Leucine-rich repeat domain
LRRs, defined by the consensus sequence LxxLxLxx(N/C)xxL, are
generally involved in protein–protein interactions (Kobe and Kajava,
2001; Enkhbayar et al., 2004; Bella et al., 2008). In the crystal structure of mouse CARMIL1, the 16-repeat LRR assumes a horseshoe
shape as found for other LRR domains (Kobe and Deisenhofer,
1996; Zwolak et al., 2013). Within this horseshoe, the LRR adopts a
typical structure, with α-helices on the convex surface and β-strands
on the concave surface (Zwolak et al., 2013). Although the secondary structure features of the repeats are characteristic of LRR domains
in general, the amino acid sequences of LRR domains in CARMILs
are more similar to one another than to those in unrelated proteins
(Kobe and Kajava, 2001), suggesting the possibility of functional
differences rather than simple structural conservation.
The notion of distinct functions for CARMIL LRR domains is supported by studies in human cultured cells, in which CARMIL2 localizes to vimentin filaments via its LRR domain (Lanier et al., 2015).
This conclusion is based on the finding that a chimeric protein in
which the LRR comes from CARMIL2 and the remainder of the polypeptide is taken from CARMIL1 colocalizes with vimentin in cells
and rescues the loss of CARMIL2 function. In contrast, the converse
chimera, composed of the LRR domain of CARMIL1 fused with all
other domains from CARMIL2, fails to localize with vimentin in cells
and is unable to rescue the loss of CARMIL2 function (Lanier et al.,
2015). In this regard, the cellular functions of all the domains of CARMIL 1 and 2 other than the LRR domain can be considered as overlapping. This conclusion is necessarily limited to the setting of the
cell culture assays and cell types examined.

Volume 28 July 1, 2017

LRR domains are bounded by ends with distinct flanking sequences, referred to as N-cap and C-cap, respectively (Bella et al.,
2008; Zwolak et al., 2013; Dao et al., 2014). N-caps are believed to
either stabilize the hydrophobic core or promote correct folding of
the LRR domain (Bella et al., 2008; Dao et al., 2014). Among CARMILs, the N-cap sequences are very similar to one another (Liang
et al., 2009; Zwolak et al., 2013; Stark and Cooper, 2015). For this
reason, the N-cap region has been useful in BLAST searches for
CARMIL family members in the genomes of various organisms
(Liang et al., 2009; Stark and Cooper, 2015), and it has been referred
to as a CARMIL homology domain (CHD; Liang et al., 2009). Unlike
the N-cap, the sequences of the C-caps are not conserved among
CARMILs, nor are they similar to C-cap sequences in other LRR domains; nevertheless, their secondary structure resembles that of the
C-cap in the LRR domain of tropomodulin (Krieger et al., 2002;
Zwolak et al., 2013).

Helical dimerization domain
CARMILs exist as homodimers in cells, and biochemical studies
reveal that homodimerization is mediated by the HD domain of
CARMIL (Zwolak et al., 2013). Isolated HD domains dimerize (Zwolak
et al., 2013), and full-length CARMILs, purified or isolated from cells,
are found as homodimers (Roncagalli et al., 2016; Wang et al.,
2016). The antiparallel nature of the dimer, revealed by small-angle
x-ray scattering (SAXS) of mouse CARMIL1, indicates that dimerization places the N-terminal PH domains in an orientation allowing
both of them to interact with a planar structure, such as the plasma
membrane (Liang et al., 2009). Indeed, the PH domain of CARMIL1
is important for membrane localization in cells (Zwolak et al., 2013).
Homodimerization of CARMILs has been documented for
Acanthamoeba CARMIL (Remmert et al., 2004), mammalian CARMIL1 (Liang et al., 2009; Zwolak et al., 2013), and mammalian
CARMIL2 (Roncagalli et al., 2016; Wang et al., 2016). Heterodimers of CARMIL1 and CARMIL2 were not observed for human
cells expressing the two isoforms at endogenous levels (Liang
et al., 2009); however, heterodimers can be induced to form in
small amounts when CARMILs are expressed at artificially high
levels (Edwards, Lanier, and Cooper, unpublished data). The amino
acid sequences of the HD domains of CARMIL1 and CARMIL3 are
more similar to one another than to the sequence of the CARMIL2
HD domain (Zwolak et al., 2013), raising the possibility that CARMIL1-CARMIL3 heterodimers may form under physiological conditions. However, structural models of HD homodimers based on
SAXS lack the resolution to address this question, and heterodimer
formation has not been properly investigated, either with purified
proteins or in cells.

Capping protein–binding region
The CARMIL CBR is part of the extended intrinsically disordered
C-terminal portion of the polypeptide that follows the HD domain. The CBR includes two conserved sequences in tandem
termed the capping protein interaction (CPI) and CARMIL-specific
interaction (CSI) motifs (Hernandez-Valladares et al., 2010;
Figure 1). This region has also been called CAH3 (for CARMIL
homology domain 3), and the portions corresponding to the CPI
and CSI motifs have been called CAH3a and CAH3b, respectively
(Zwolak et al., 2010b).
The CPI motif, with the consensus sequence LxHxTxxRPK(x)6P, is
found in a diverse set of otherwise unrelated proteins, all of which
bind directly to CP (Bruck et al., 2006). For CARMIL1 and CARMIL2, a
number of cellular functions have been demonstrated to depend on
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the ability of the motif to bind CP (Edwards et al., 2013, 2014; Lanier
et al., 2015). Two cocrystal structures of CP, one in complex with the
full CBR of CARMIL1 and the other with the CPI motif of CD2AP, revealed a conserved set of close contacts between the CPI motifs and
CP (Hernandez-Valladares et al., 2010; Takeda et al., 2010).
In contrast to the more common CPI motif, the CSI motif (consensus sequence RxDEGxEEFFxKR; Hernandez-Valladares et al.,
2010; Zwolak et al., 2010b) is present only in proteins of the CARMIL
family. Moreover, the CSI is limited to CARMILs from vertebrates
and higher invertebrates; CARMILs from lower eukaryotes, including Acanthamoeba, Dictyostelium, and Caenorhabditis, lack the
consensus sequence (Figure 1; Zwolak et al., 2010b; Edwards et al.,
2014). Whereas the CPI motif on its own is sufficient to bind to CP
and decrease its actin-binding activity, the CSI motif binds CP
weakly and has relatively little ability to inhibit its activity. Nevertheless, as part of the CBR, the CSI makes an important contribution to
the binding and inhibition of CP (Hernandez-Valladares et al., 2010;
Zwolak et al., 2010b).
Actin and the CBR bind to distinct sites on the mushroomshaped CP α/β heterodimer. The barbed end of the actin filament
binds to the top surface of the mushroom (Narita et al., 2006; Kim
et al., 2010), whereas the CBR binds to the mushroom stalk via its
CPI and CSI motifs (Hernandez-Valladares et al., 2010; Takeda et al.,
2010). The CPI motif binds along the surface of about half of the
perimeter of the mushroom stalk, covering parts of both the CP αand β-subunits. Contact residues between CPI and CP, identified in
the cocrystal structure (Hernandez-Valladares et al., 2010; Takeda
et al., 2010), have been documented to be important for this interaction in biochemical and cell biological assays (Edwards et al.,
2013, 2015; Lanier et al., 2015).
The short linker sequence that connects the CPI and CSI motifs
was not resolved in cocrystal structures, suggesting that it may not
bind residues on the surface of CP (Hernandez-Valladares et al.,
2010). Replacing the residues of the linker sequence with a set of
alternating Ala and Gly residues did not affect the ability of the CBR
to bind and inhibit CP activity in actin-capping assays (Kim et al.,
2012), confirming the absence of functionally important close contacts in this region. However, it remains possible that the physical
properties of the linker affect the kinetics and thermodynamics of
CBR binding through effects on the physical properties of the intrinsically disordered domain, including the adjacent CPI and CSI motifs.
The binding of CARMIL to CP has an allosteric effect on the conformation of CP’s actin-binding surface. CARMIL binding promotes
occupancy of a CP state that is more similar to unbound CP than to
actin-bound CP (Figure 2). This state has structural and dynamic
properties that decrease the binding affinity of CP for the barbed
end of the actin filaments (Hernandez-Valladares et al., 2010; Kim
et al., 2012; Edwards et al., 2013). Evidence for this conclusion includes the observation that the CBR domain of CARMIL decreases
the actin capping activity of CP by 250-fold (Kim et al., 2012). In addition, CBR binding leads to an increase in the dissociation rate of
CP from the barbed end, suggesting that a molecule of CBR can
bind to a molecule of CP bound to a capped actin filament, forming
a trimolecular complex (Fujiwara et al., 2010; Hernandez-Valladares
et al., 2010; Kim et al., 2012; Lanier et al., 2015). This is an important
point, relevant to cellular function—CARMIL binding to CP decreases
but does not abolish the capping activity of CP, and this trimolecular
complex can exist in vitro and, presumably, in vivo (Yang et al., 2005).
These biochemical observations have two potential implications
for the function of CARMIL (and other CPI proteins) in cells. First,
CARMIL may recruit or target the barbed-end capping activity of CP
to a site of actin assembly. In the case of Arp2/3-nucleated actin as1716 | B. C. Stark et al.

sembly, capping barbed ends is necessary for the reconstitution of
actin polymerization and actin-based motility from purified components (Loisel et al., 1999). In the case of formin-nucleated actin
assembly, CP and formins antagonize each other functionally (Breitsprecher and Goode, 2013), and they can simultaneously bind to
the barbed end of an actin filament, forming a so-called decision
complex. The decision complex resolves with either capping of the
filament by CP and dissociation of formin from the tip, or removal of
CP from the barbed end, followed by formin-mediated actin polymerization (Bombardier et al., 2015; Shekhar et al., 2015). Both
Arp2/3- and formin-mediated actin polymerization presumably rely
on CP to limit the length of the actin filaments and help to maintain
a pool of free actin monomers.
The second implication of the foregoing biochemical observations is that CARMILs may modulate the capping activity of CP,
“tuning it down” to levels that are physiologically relevant for the
cytoplasmic concentrations of CP and barbed ends (Yang et al.,
2005; Uruno et al., 2006; Hernandez-Valladares et al., 2010; Kim

FIGURE 2: Principal component analysis (PCA) of CP. Top, PCA of
molecular dynamics simulations of the structural conformations of CP.
The simulations were begun with CP that was either free (gray
contour shading), bound to F-actin (blue dots and contour lines), or
bound to CARMIL (red dots and contour lines). The results were
projected onto the same conformational space; existing CP structures
were overlaid as green dots. Based on this analysis, CARMIL-bound
CP exists in a conformational space more like that of unbound CP
(gray) than to that of F-actin–bound CP. Bottom, overlay of protein
structures, depicting the conformations that correspond to the peaks
of CARMIL-bound and F-actin bound CP. This analysis supports the
findings that CARMIL allosterically inhibits CP by eliciting changes to
the actin-binding surface, holding CP in a conformation similar to the
free state. Used with permission from Kim et al. (2012).
Molecular Biology of the Cell

et al., 2012; Lanier et al., 2015). Consistent with this model, when
the CBR-CP complex binds to actin barbed ends in vitro, CP dissociates from the barbed end at a faster rate, similar to the time frame
for interactions of CP with the actin cytoskeleton in cells (Miyoshi
et al., 2006; Fujiwara et al., 2010). This action of CARMIL may contribute to the disassembly and turnover of actin filaments in cells by
making the capping of barbed ends more dynamic.
The potential models of “targeting” CP and “tuning” its capping activity are not exclusive and may both exist in cells. The
relevance of these models is supported by the cellular phenotypes of a CP point mutant that is unable to bind to CPI motifs
(Edwards et al., 2015). Although this mutant has normal actincapping activity in biochemical assays, it provides little or no
actin-related function in cells. Dominant-negative and expressionrescue approaches showed that the CP mutant phenocopies the
simple loss of CP. These findings led to the conclusion that CP
function in cells depends on an interaction with a protein that
contains a CPI motif.
CP can be inhibited by the protein V-1 in vitro, and V-1 binds to
the actin-binding surface of CP, acting as a direct competitor for the
capping of barbed ends (Bhattacharya et al., 2006; Takeda et al.,
2010; Zwolak et al., 2010a; Fujiwara et al., 2014). If CP is inhibited by
the binding of V-1 in cells, as revealed by a study with Dictyostelium
(Jung et al., 2016), then one attractive model is that CARMILs, along
with other proteins containing CPI motifs, activate rather than inhibit
CP, as first suggested by Fujiwara et al. (2014). In this model, activation of CP is a consequence of a CPI-motif protein binding to the
CP/V-1 complex, increasing the rate of V-1 dissociation by the same
allosteric mechanism that decreases actin capping and promotes
uncapping (Takeda et al., 2010; Fujiwara et al., 2014; Edwards et al.,
2015).

Membrane-binding domain
CARMILs have membrane-binding domains that consist of unstructured protein regions with basic and hydrophobic residues. This
type of membrane-binding domain binds to lipid bilayers through a
combination of electrostatic and hydrophobic interactions (Heo
et al., 2006). In this context, binding requires a high density of basic
and hydrophobic residues, but it is largely independent of the exact
sequence (Papayannopoulos et al., 2005; Heo et al., 2006; Brzeska
et al., 2010). A search algorithm designed to detect amino acid sequences with these features identified one in mouse CARMIL1, and
the predicted region was found to bind to acidic phospholipids with
a binding affinity in the micromolar range (Brzeska et al., 2010). This
initial study used in vitro lipid-binding assays and a relatively large
fragment of mouse CARMIL1. Later, smaller fragments of human
CARMIL1, CARMIL2, and CARMIL3 containing the MBDs were
found to be sufficient to target GFP to the plasma membrane in
cells, including to the leading edge of migrating cells, which is an
active site of actin polymerization (Lanier et al., 2016).
These studies showed that the CARMIL MBD is sufficient for
membrane and lipid binding. In addition, the MBD has been shown
to be necessary for membrane localization of full-length CARMILs
in cells and is also required for the function of CARMIL in cells. Specifically, for CARMIL2, a series of point mutations in the MBD revealed that the MBD is essential for membrane localization and for
function (Lanier et al., 2016). Both full-length CARMIL2 and the Cterminal half alone required the MBD for their membrane localization in cells. For full-length CARMIL2, the MBD was required to
rescue the phenotypes caused by the loss of endogenous CARMIL2, revealing its requirement for CARMIL2 function within cells
(Lanier et al., 2016).
Volume 28 July 1, 2017

For CARMIL1 and CARMIL3, the necessity of the MBD for function in cells has not been investigated directly. However, for CARMIL1, observations from the literature strongly suggest that the
MBD is important. Specifically, two studies, using different approaches to examine the function of CARMIL1 mutants deficient for
CP binding, provide evidence for MBD function as well. In the first
study, a CARMIL1 mutant with a 123-amino acid internal deletion
that encompasses both the CBR and the MBD failed to rescue cell
migration phenotypes of CARMIL1-depleted cells in wound-healing
assays (Yang et al., 2005). In the second study, a CARMIL1 CP-binding mutant with substitutions for two highly conserved residues of
the CPI consensus sequence, leaving both the CSI motif and the
MBD intact, was largely able to rescue the wound-healing cell
migration phenotype in CARMIL1-depleted cells (Edwards et al.,
2013). One key difference between the CARMIL1 mutant constructs
in the two studies is the presence of the MBD in the expression
construct for the latter but not the former. Taken together, these
studies support the hypothesis that the MBD is necessary for the
cellular function of CARMIL1, consistent with the results obtained
for CARMIL2 described earlier.
The MBDs of different CARMIL isoforms have functions that are
sufficiently similar as to be interchangeable in cells in some settings.
As discussed earlier, the MBD of CARMIL1 was able to substitute for
that of CARMIL2 in a chimera consisting of the PH domain of CARMIL1, the LRR domain of CARMIL2, and the C-terminal half of CARMIL1 (including the CBR and MBD), rescuing cellular phenotypes
caused by depletion of endogenous CARMIL2 (Lanier et al., 2016).
The presence of the MBD and the CSI motif is a distinctive feature of CARMILs among the diverse and otherwise unrelated set of
CPI motif–containing proteins (Lanier et al., 2016). Thus the MBD
and the CSI motif may provide functions that distinguish the cellular
roles of CARMILs from those of other CPI-motif proteins. The close
proximity of the MBD to the CBR, which includes both CPI and CSI
motifs, raises the possibility that the function of the MBD is to target
regulation of CP and actin assembly to the vicinity of the membrane
(Lanier et al., 2016).

Proline-rich domain
The C-terminal domains of CARMILs are rich in proline residues.
Indeed, the initial discoveries of CARMILs in Acanthamoeba and
Dictyostelium were based on direct physical interactions between
the PRDs of CARMILs with the SH3 domains of the tails of certain
class I myosins (Xu et al., 1995, 1997; Zot et al., 2000; Jung et al.,
2001). Acanthamoeba and Dictyostelium CARMILs have their CBR
at the extreme end of the C-terminus, and they lack the extended
C-terminal PRD seen in vertebrates (Figure 1); however, PxxP motifs
responsible for SH3 binding are present just upstream of the CBR
(Xu et al., 1995, 1997; Zot et al., 2000; Jung et al., 2001).
In vertebrates, the CARMIL1 PRD binds to myosin-IE, a class I
myosin with an SH3 domain in its tail (Liang et al., 2009). Whereas
CARMIL1 PRD has many PxxP motifs, the one(s) critical for SH3
binding have not been identified. The physiological importance of
this interaction has not been assessed; however, the tail domain of
myosin-IE appears to stabilize focal adhesions at the leading edge
of migrating cells (Gupta et al., 2013).
CARMIL2 does not bind to myosin-IE, based on a direct comparison with CARMIL1 (Liang et al., 2009). However, the CARMIL2 PRD
includes 10 PxxP motifs, and it interacts with the signaling adaptor
GRB2, which contains two SH3 domains. This interaction with GRB2
appears to couple CARMIL2 to CD28 signaling (Roncagalli et al.,
2016), as discussed later. One can imagine that future studies will
uncover other binding partners for the PRDs of CARMILs.
CARMIL function
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Cellular functions
Isoform

Actin

Expression

Signaling

Human disease

Invertebrate

NA

NA

Decreased NF-κB signaling

NA

CARMIL1

Skin, testis, spleen

CP regulation,
macropinocytosis

Wound healing, increased Trio
signaling

Gout, ARDS

CARML2

Brain, spinal cord, kidney,
thymus, spleen, bone
marrow, eyes

CP regulation, cell polarity Wound healing, CD28-mediated
T-cell activation, increased NF-κB
signaling

Immune function, T-cell
development

CARMIL3

Brain, eyes, spinal cord,
heart, testis

NA

Oncofetal gene

NA

NA, not available.

TABLE 1: Summary of CARMIL functions in cells and organisms.

ROLES OF CARMILS AT THE CELLULAR AND
ORGANISMAL LEVELS
CARMIL expression during development and differentiation
The patterns and timing of expression of CARMIL isoforms in vertebrate cells and tissues have been addressed, but only to a limited
extent (Table 1). As noted earlier, vertebrates have three genes from
which three highly conserved isoforms of CARMIL are expressed
(Figure 1).
In zebrafish, the three isoforms show distinct spatial and temporal expression patterns through development and differentiation
(Stark and Cooper, 2015). Of the three, CARMIL1 is most widely
expressed, being present in the skin, fins, branchial arches, gut, and
cloaca (Stark and Cooper, 2015). An RNA-sequencing study of zebrafish skin found only the CARMIL1 isoform ( Wang, Cokus, and
Sagasti, personal communication). CARMIL2 is expressed at high
levels in brain and spinal cord and at lower levels in eye and developing kidney (Trinh et al., 2011; Stark and Cooper, 2015). CARMIL3
is expressed at high levels in brain and eye, with lower levels in the
spinal cord. It is also expressed in the developing heart and is the
only isoform observed in this organ (Stark and Cooper, 2015).
Studies of the expression of CARMIL isoforms in other vertebrates have been more limited. An analysis of five isolated mouse
tissues revealed that CARMIL1 was highly expressed in testis and
weakly in spleen and brain; CARMIL2 was highly expressed in thymus and spleen and weakly in bone marrow; and CARMIL3 was expressed in brain and testis (Liang et al., 2013). In a study of human
tissues, CARMIL2 expression, assayed by reverse transcription PCR
(RT-PCR), was detected in 30 different tissues, including skin (Matsuzaka et al., 2004). A study of CARMIL3 expression in human cells
identified it as an oncofetal gene; it was found in brain, colon, heart,
kidney, liver, lung, skeletal muscle, and spinal cord of both adult and
fetal tissue samples, based on RT-PCR assays (Hsu et al., 2011).
The patterns of expression of CARMIL isoforms in vertebrates
can also be obtained from the RNA-sequencing and microarray data
curated in the Expression Atlas at the European Bioinformatics Institute (Kapushesky et al., 2012; Petryszak et al., 2014). In spite of certain inconsistencies across data sets, even for the same organism
and tissue, several trends are clear. First, CARMIL1 is the most
widely expressed isoform, detectable within a variety of tissues
across multiple species. Analyses of skin revealed CARMIL1 expression in sheep (Bakhtiarizadeh et al., 2016), mice (Huntley et al.,
2016), and humans (FANTOM Consortium and the RIKEN PMI and
CLST (DGT) et al., 2014; Uhlen et al., 2015; Human Protein Atlas
[www.proteinatlas.org]). Second, CARMIL2 and CARMIL3 are the
isoforms most commonly expressed in brain tissues across a variety
of organisms (Kapushesky et al., 2012; Petryszak et al., 2014).
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Collectively the expression studies reveal that the three CARMIL
isoforms have isoform-specific expression patterns, but that, in some
cases, two or three isoforms are found within the same cells and tissues. For example, several human cultured cell lines express all three
CARMIL isoforms (Liang et al., 2009). Further studies of the expression of CARMIL proteins within organisms would have value, in part
to address apparent inconsistencies among previous studies.

Cellular functions of CARMILs
Because CARMILs are large, multidomain proteins, one might expect them to play multiple roles within cells. Indeed, although the
CBR domain and actin-based functions have received the most
attention, recent studies reveal roles in signaling networks and in human disease that may involve additional CARMIL domains (Table 1).
Regulation of actin assembly via CP. CARMILs contain CPI motifs;
therefore their actin-related cellular functions need to be considered
in the context of the otherwise-unrelated proteins with CPI motifs,
as previously reviewed (Edwards et al., 2014). All CPI-motif proteins
localize to membranes and may serve as scaffolds for the recruitment
and activation of CP at sites of actin assembly. The physiological
importance of the CPI motif–CP interaction in cells has been
demonstrated for several of these proteins. For CD2AP, a rescue
construct bearing mutations that affect CPI residues fails to rescue
CP localization in CD2AP-null cells (Zhao et al., 2013). For CKIP-1,
interactions between the CPI motif and CP are required for increases
in levels of cellular actin and F-actin caused by overexpression
(Canton et al., 2006). For both CARMIL1 (Edwards et al., 2013) and
CARMIL2 (Lanier et al., 2015), loss of CPI-CP interactions results in
phenotypes reminiscent of the loss of CP function or localization.
In addition to the aforementioned studies investigating the role
of the CPI residues in the interaction with CP, a complementary
study probed CP residues for their relevance by alanine substitutions for two CP β-subunit residues in close contact with CPI in cocrystal structures (Hernandez-Valladares et al., 2010; Edwards et al.,
2015). This mutant CP retained its full actin-binding capability; however, when expressed in cells, it mimicked the phenotype of loss of
function of CP (Edwards et al., 2015). This study concluded that CP
requires an interaction with a CPI-motif protein to function.
On the other hand, the CPI motifs of CARMIL1 or CARMIL2 do
not appear to be necessary for all cellular functions. In particular, cell
migration during wound-healing assays with cultured fibroblasts
showed little dependence on the CPI motif (Edwards et al., 2013;
Lanier et al., 2015). Similarly, in T-cells, the CARMIL2 CPI motif was
not required for the CARMIL2 functions in CD28 costimulation and
downstream signaling during T-cell activation (Roncagalli et al., 2016).
Molecular Biology of the Cell

CARMIL proteins as signaling scaffolds
NF-κB signaling pathway. In insects, treatment with a nicotinic acetylcholine receptor agonist, clothianidin, leads to increased expression of the single CARMIL gene (in flies, Dmel/LRR; in bees, Amel/
LRR), and this leads to a decrease in NF-κB activation (Di Prisco
et al., 2013). This deficiency in NF-κB activation was found to
account for an increase in the effects of pathogens on insects previously exposed to neonicotinoids such as clothianidin. In this setting,
CARMIL functions as a negative regulator of NF-κB signaling downstream of receptor-based signaling.
Signaling promoting T-cell development. In higher organisms,
CARMIL2 (also known as RLTPR) contributes to the immune system
by controlling the development of certain T-cell subsets: Tregs and
effector memory CD4+ T-cells (Liang et al., 2013; Roncagalli et al.,
2016; Sorte et al., 2016; Wang et al., 2016). Within murine T-cells,
CARMIL2 is required for proper localization of PKCθ and CARMA1
after CD28 stimulation (Liang et al., 2013). This study identified a
point mutation that affects the mouse CARMIL2 LRR domain
(RltprBas) and abrogates the effects of CD28 stimulation while
retaining the CP-binding activity of CARMIL2. Ligand-induced CD28
internalization was accelerated in cells expressing the mutant CARMIL2, presumably due to decreases in “drag” resulting from loss
of interactions with PKCθ, CARMA1, and downstream molecules
(Liang et al., 2013; Roncagalli et al., 2016). CARMIL2 was required
for the production of interleukin-2 downstream of the CD28 signaling pathway; this required its PH, LRR, and PRD domains, but the
CP-binding activity of the CPI motif was dispensable (Roncagalli
et al., 2016). Of interest, another CPI-motif protein, CapZIP, was
found to be required, suggesting that the presence of the CPI motif
of CapZIP allows for the loss of the CARMIL2 CPI motif (Tian et al.,
2015; Roncagalli et al., 2016).
Rho-family GTPase signaling pathway. Several studies have implicated CARMIL in Rac signaling via the dual–guanine nucleotide exchange factor (GEF) protein Trio. First, the single CARMIL gene in
Caenorhabditis elegans (CRML-1) was detected in a genetic screen
for inhibitors of the migration of neurons and axon growth cones
(Vanderzalm et al., 2009). Genetic and biochemical interactions
revealed that the inhibitory effect of CARMIL was mediated by Trio
(UNC-73; Vanderzalm et al., 2009). A subsequent genetic study,
investigating epithelial intercalation in the epidermis of this organism, also revealed that CARMIL inhibits Trio (Walck-Shannon et al.,
2015). In this case, loss of CARMIL, and thus loss of Trio inhibition,
led to loss of the polarized actin-rich protrusions that are required
for intercalation among epithelial cells. In both studies, CARMIL
functioned as a net negative regulator of Rac and RhoG, proteins
that are activated by Trio’s GEF domains and promote Arp2/3-
mediated actin polymerization (Walck-Shannon et al., 2015).
In cultured human cells, loss of CARMIL1, but not CARMIL2, led
to the loss of Rac1 activation that occurs when cells spread on a
fibronectin-coated substrate (Liang et al., 2009). In that study, Trio
also interacted biochemically with CARMIL1 but not with CARMIL2.
Later, the ability of CARMIL1 to enhance Rac1 activation was found
to be independent of the ability of CARMIL1 to bind CP (Edwards
et al., 2013). These results for CARMILs in humans and worms differ
in one paradoxical respect. Whereas in human cells, the effect of
CARMIL1 on Rac1- and Arp2/3-mediated actin assembly was positive, in worms, the net effect of CARMIL was negative. This discrepancy in outcome may reflect differences in the organisms, including
the fact that humans have three CARMIL isoforms, which have both
distinct and overlapping functions (Walck-Shannon et al., 2015).
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CARMIL proteins in human disease. CARMIL genes and proteins
have been implicated in several human diseases. A variant of the
gene encoding CARMIL1 (LRRC16A) has been associated with
increased susceptibility to gout (Kolz et al., 2009; Sakiyama et al.,
2014). This led to the proposal that CARMIL1-based regulation
of CP, and thus of actin, influences the function of the uratetransporting macromolecular complex through an unknown
mechanism (Sakiyama et al., 2014).
CARMIL1 variants have also been implicated in acute respiratory
distress syndrome (ARDS; Wei et al., 2015, 2017); single-nucleotide
polymorphisms (SNPs) have been associated with blood platelet
count, an important parameter of clinical outcome. One SNP, studied in detail, causes a single–amino acid change in the LRR domain,
decreased expression of mRNA, increased patient survival, and a
decreased rate of platelet loss during the course of the illness (Wei
et al., 2017). One potential scenario is that decreased CARMIL1
function impairs the actin cytoskeleton of the platelet, which lessens
platelet activation and therefore mitigates the loss of circulating
blood platelets. Paradoxically, poor platelet function has a beneficial
effect for the ARDS patient because loss of platelets is a critical negative determinant.
In the case of the CARMIL2 gene (RLTPR), three studies identified
mutations in families with primary immunodeficiencies (Sorte et al.,
2016; Wang et al., 2016; Schober et al., 2017). In one of these studies, a missense mutation affecting the LRR domain (L603H) was
found in four patients from three Norwegian families. The patients
presented with warts, molluscum contagiosum, dermatitis, and evidence of immune dysfunction and susceptibility to viral infection in
other systems (Sorte et al., 2016). In these individuals, levels of regulatory and CD4+ T-cells were low, as was the synthesis of interferon-γ
in CD4+ T-cells and NK cells.
In the second study of CARMIL2, three point mutations (L372R,
L489Q, and Q817X) were found in six individuals from three families
(Wang et al., 2016). Homozygous individuals experienced mucocutaneous infections associated with decreased levels of regulatory and
memory CD4+ T-cells as well as memory B-cells. The latter were unable to activate NF-κB after stimulation of B-cell receptors, indicating
that B-cell dysfunction was independent of activation by CD4+ T-cells
(Wang et al., 2016). Two of the mutations (L372R and L489Q) affect
the LRR domain of CARMIL2, and the third (Q817X) introduces a stop
codon in the HD domain. The missense alleles are associated with
low levels of CARMIL2 protein, and the nonsense allele is expected to
produce a truncated protein that lacks important functional domains
in the intrinsically disordered C-terminal half of the protein.
In a third study of immunodeficiencies caused by CARMIL2 mutations, nonsense mutations in the linker/N-cap region or the Nterminal half of the LRR domain affected CD28-based activation,
development, and function of T-cells (Schober et al., 2017). Patients
lacked regulatory T-cells and suffered from immunodeficiency syndromes similar to those in patients in the studies discussed earlier
(Sorte et al., 2016; Wang et al., 2016; Schober et al., 2017). In T-cells
isolated from patients, levels of F-actin at the leading edge were
decreased and the microtubule network was disorganized. When
migrating, the T-cells were often multipolar, with decreased directed
motion (Schober et al., 2017), reminiscent of the effects of CARMIL2
knockdown in a cultured cell line (Liang et al., 2009). These mutations also resulted in decreased activation of NF-κB signaling
(Schober et al., 2017).
Overall these three studies of human patients suggest that the
effects of CARMIL2 mutations in are likely related to the role of
CARMIL2 in CD28 costimulation and T-cell development, as discussed earlier.
CARMIL function

| 1719

Molecular models of CARMIL function in cells
Here we consider working models for CARMIL function in cells as a
framework for current knowledge and a basis for future studies. The
biochemical, structural, and cellular properties of CARMIL proteins
suggest that they interact with signaling networks to regulate the
dynamics of the actin cytoskeleton at membranes. CARMILs move
to the membrane either by passive diffusion or active transport.
Once near the membrane, CARMILs may bind directly to membrane lipids and then recruit and/or inhibit CP via their CBR domains, as well as interact with signaling molecules.
One open question is whether the CBR domains of full-length
CARMILs are found in an autoinhibited state in cells. In the case of
Acanthamoeba CARMIL, a set of biochemical experiments with purified proteins provided compelling evidence that autoinhibition
does occur (Uruno et al., 2006). In that study, a C-terminal fragment
of CARMIL, which included the CBR, bound to CP with ∼20-fold
greater affinity than did full-length CARMIL. Moreover, mild proteolytic cleavage of full-length CARMIL generated the more active Cterminal fragment. On the other hand, in a separate study with
mouse CARMIL1, full-length CARMIL1 and its CBR fragment were
similarly effective in actin polymerization-based assays measuring
CP inhibition (Yang et al., 2005). The difference in the results from
the two studies may be attributable to a notable difference between

the proteins—the CBR of Acanthamoeba CARMIL is at the C-terminus and lacks the CSI-motif, whereas the CBR of mouse CARMIL1 is
separated from the C-terminus by ∼300 amino acid residues and
contains the CSI motif. Of course, differences in solution and other
conditions may also affect the accessibility of the CBR in the fulllength protein because the C-terminal regions of both proteins are
intrinsically disordered.
We next consider and propose models with additional details for
vertebrate CARMIL1 and CARMIL2, based on findings from published studies. For CARMIL3, the paucity of published data prevents
a detailed discussion of models. The domain structure of CARMIL3
is similar to those of CARMIL1 and CARMIL2; however, the isoforms
display conserved sequence differences that suggest the presence
of distinct functions.
Model for CARMIL1. This model proposes that CARMIL1
homodimers are transported to the plasma membrane along actin
filaments. Class I myosins, namely myosin-1E and myosin-1F, bind
PxxP motifs of CARMIL1’s PRD via their SH3 domains, and they carry
CARMIL1 toward the membrane-associated barbed ends of actin
filaments (Figure 3). The PH domain and MBD of CARMIL1 then
bind directly to membrane lipids. Arp2/3 complex is activated at
or near the membrane by signals from receptors transduced
by small GTPases. Arp2/3 nucleates actin
polymerization, and its branched network
of actin filaments requires CP for proper
assembly and force production.
In this model, CP is recruited to the
membrane by CARMIL1. Binding of CARMIL1 to CP promotes dissociation of the CP
inhibitor V-1, which activates CP for barbedend capping. In addition, the fact that CP is
bound to CARMIL1 provides for capping
with kinetic rate constants and binding affinities that are relevant to the time scale of
actin-based motility and the physiological
concentrations of the reacting. Experimental evidence supports the existence of a
pool of CP/V-1 complex in cells; most of the
cellular population of CP is bound to V-1
(Fujiwara et al., 2014), and modeling studies
suggest that a pool of CP diffuses slowly
(McMillen and Vavylonis, 2016).
While at the membrane, CARMIL1 also
interacts with the dual-GEF Trio, promoting
signaling by RhoG, Rac1, and/or RhoA. The
resulting increase in Rac1 activity promotes
actin assembly by positively regulating the
WAVE complex, creating a positive feedback loop for Arp2/3-mediated actin nucleation (Figure 3).

FIGURE 3: Models for CARMIL1 and CARMIL2 function within cells. (A) CARMIL1 is transported
to the membrane via myosin-IE. CARMIL1 interacts with the membrane via PH domain and
MBD. At the membrane, CARMIL1 recruits CP and relieves it from inhibition by V-1. Released
V-1 then activates NF-κB signaling. CARMIL1 also activates Trio, which leads to an increase in
Rac1 activation and Arp2/3-mediated actin assembly. (B) CARMIL2 is transported to the
membrane via an interaction with vimentin filaments, where it then associates with the
membrane via its MBD. In migrating cells, the CARMIL2 model is similar to CARMIL1 in that the
CBR interacts with CP bound by V-1. This activates CP, allowing for barbed-end capping.
(C) During CD28 costimulation to activate T-cells, membrane-localized CARMIL2 interacts with
the adaptor protein GRB2, leading to downstream activation of CARMA1, PKCθ, and NF-κB
activation.
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Model for CARMIL2. Certain aspects of
the model proposed for CARMIL2 function
resemble those of CARMIL1, including the
ability to recruit and regulate CP to promote
cell migration, lamellipodial assembly,
membrane ruffling, and macropinocytosis,
based on the loss-of-function phenotypes
for CARMIL1 and CARMIL2. Overlapping
functions for CARMIL1 and CARMIL2 were
also suggested by the observation that a
Molecular Biology of the Cell

chimera consisting of the PH domain of CARMIL1, the LRR domain
of CARMIL2, and the C-Terminal half of CARMIL1 (including the
CBR and MBD), rescues cellular phenotypes caused by the depletion
of endogenous CARMIL2 (Lanier et al., 2015)
Transport of CARMILs 1 and 2 to the membrane are likely to differ. Only CARMIL1 associates with myosin 1E (Liang et al., 2009),
and only CARMIL2 associates with dynamic vimentin filaments
(Liang et al., 2009; Lanier et al., 2015). Thus vimentin filaments may
carry CARMIL2 toward the membrane by interacting with its LRR
domain (Figure 3), for which the biochemical mechanism is not yet
understood.
At the membrane of migrating cells, CARMIL2 is proposed to
contribute to actin assembly by regulating CP in the manner
described for CARMIL1 (Figure 3). However, both CARMIL1 and
CARMIL2 are necessary for lamellipodial dynamics and ruffling,
and neither protein is able to rescue the loss of the other, revealing that certain aspects of their function must be distinct (Liang
et al., 2009). CARMIL2 is known to differ from CARMIL1 in ways
that are potentially important for regulation of actin assembly. Unlike CARMIL1, CARMIL2 does not contribute to Rac1 activation,
but it does affect the level of expression of myosin-IIB (Liang
et al., 2009).
CARMIL2 plays a scaffolding role in T-cell development, which
does not require the function of the CPI motif and is thus independent of CP-based regulation of actin. Instead, this role requires the
PH, LRR, and PRD domains of CARMIL2 (Roncagalli et al., 2016;
Wang et al., 2016). This role may involve CARMIL2-interacting proteins such as transmembrane receptors (CD28 and CD8B), GEFs
(VAV1 and DOCK8), phosphatases (PRPRF, PRPRC, and PTPN6),
adaptor proteins (FYB, SIT1, GRAP2, GRB2, and Carma1), and a
GAP (RASL3; Roncagalli et al., 2016). During CD28 costimulation of
T-cells, CARMIL2 is recruited to the activated receptor and binds an
adaptor protein (GRB2 or GRAP2). Here CARMIL2 serves as a binding partner for CARMA1, which activates protein kinase Cθ (PKCθ)
and thus leads to NF-ΚB activation, thereby promoting the activation and proliferation of T-cells (Figure 3).
These models suggest that CARMIL1 and CARMIL2 activate NFκB signaling; however, as described earlier, work in insects shows
that CARMIL negatively regulates NF-κB (Di Prisco et al., 2013). In
an alternative model that accounts for negative regulation of NF-κB,
CARMIL removes CP from the barbed ends of filaments, allowing
it to bind to V-1, thereby preventing V-1 from activating NF-κB
(Bhattacharya et al., 2006).

SUMMARY, CONCLUSIONS, AND FUTURE DIRECTIONS
CARMILs are a family of large, multidomain proteins with important
cellular functions involved in development, differentiation, and disease. All CARMILs bind to CP and regulate actin assembly in biochemical experiments with purified proteins; in cells, this interaction
is important for the regulation of actin assembly and actin-based
motility. CARMILs are often localized to membranes, where they
regulate membrane-associated actin assembly. The roles of CARMILs
as CP regulators have been documented relatively well; however,
regulation of CP by CARMIL is likely to be complementary to and
distinct from CP regulation by other CPI-motif proteins (Edwards
et al., 2014). Exciting newer work has begun to uncover novel CPindependent roles for CARMILs.
CARMIL-family proteins are present in many eukaryotes, with the
notable exceptions of plants and fungi. Vertebrates have three
highly conserved genes that encode CARMILs, and these isoforms
have cellular and biochemical functions that are overlap partially but
also have distinct functions. For example, only CARMIL2 interacts
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with vimentin filaments within the cell, and it may mediate the effects of vimentin filaments on actin assembly at membranes.
It is likely that many functions of CARMILs remain to be identified. Indeed, the effects of mutations in model organisms and human patients have only recently come to light. In terms of human
disease, mutations of CARMIL1 and CARMIL2 have been implicated
in several different disorders. Much also remains to be learned
about the functional implications of the interactions of CARMILs
with known binding partners. Finally, the functions of many of the
CARMILs domains are not yet known. This new information will be
important for understanding the molecular mechanisms of a diverse
set of biological and pathological processes, many of which depend
on the function of the actin cytoskeleton.
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